These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23367850)

  • 1. [A study for the necessity of virus titer of varicella vaccine presently used].
    Ozaki T; Nishimura N; Gotoh K; Funahashi K
    Kansenshogaku Zasshi; 2012 Nov; 86(6):749-54. PubMed ID: 23367850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of Booster Vaccination in Children with Primary Vaccine Failure after Initial Varicella Vaccination].
    Ozakiv T; Nishimura N; Gotoh K; Funahashi K; Yoshii H; Okuno Y
    Kansenshogaku Zasshi; 2016 May; 90(3):291-6. PubMed ID: 27529963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunogenicity of additional varicella vaccination 3-5 years after the initial vaccination].
    Ozaki T; Nishimura N; Gotoh K; Funahashi K; Yoshii H; Okuno Y
    Kansenshogaku Zasshi; 2013 Jul; 87(4):409-14. PubMed ID: 23984589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-varicella-zoster virus antibody titers and seroprotection status from before the first dose of varicella vaccination to before entering elementary school in one region in Japan.
    Ozaki T; Nishimura N; Gotoh K; Takemoto K
    Vaccine; 2023 Feb; 41(6):1274-1279. PubMed ID: 36631357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection.
    Li S; Chan IS; Matthews H; Heyse JF; Chan CY; Kuter BJ; Kaplan KM; Vessey SJ; Sadoff JC
    Pediatr Infect Dis J; 2002 Apr; 21(4):337-42. PubMed ID: 12075766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical studies of varicella vaccine at a regional hospital in Japan and proposal for a varicella vaccination program.
    Ozaki T
    Vaccine; 2013 Dec; 31(51):6155-60. PubMed ID: 24183712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
    Silber JL; Chan IS; Wang WW; Matthews H; Kuter BJ
    Pediatr Infect Dis J; 2007 Jul; 26(7):572-6. PubMed ID: 17596796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy infants, children, and adolescents.
    Paradis EM; Tikhonov O; Cao X; Kharit SM; Fokin A; Platt HL; Wittke F; Jotterand V
    Hum Vaccin Immunother; 2021 Nov; 17(11):4183-4189. PubMed ID: 34702124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of immunity against VZV by giving live varicella vaccine to the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay.
    Takahashi M; Okada S; Miyagawa H; Amo K; Yoshikawa K; Asada H; Kamiya H; Torigoe S; Asano Y; Ozaki T; Terada K; Muraki R; Higa K; Iwasaki H; Akiyama M; Takamizawa A; Shiraki K; Yanagi K; Yamanishi K
    Vaccine; 2003 Sep; 21(25-26):3845-53. PubMed ID: 12922118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy adults.
    Paradis EM; Tikhonov O; Cao X; Kharit SM; Fokin A; Platt HL; Banniettis N
    Hum Vaccin Immunother; 2021 Nov; 17(11):4177-4182. PubMed ID: 34473594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity and specificity of different antibody tests for detecting varicella-zoster virus.
    Otani N; Shima M; Tanimura S; Ueda T; Ichiki K; Nakajima K; Takesue Y; Honjo K; Okuno T
    J Infect Chemother; 2020 Dec; 26(12):1283-1287. PubMed ID: 32843302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of subcutaneous versus intramuscular Oka/Merck varicella vaccination in healthy children.
    Dennehy PH; Reisinger KS; Blatter MM; Veloudis BA
    Pediatrics; 1991 Sep; 88(3):604-7. PubMed ID: 1881743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy.
    Durando P; Esposito S; Bona G; Cuccia M; Desole MG; Ferrera G; Gabutti G; Pellegrino A; Salvini F; Henry O; Povey M; Marchetti F
    Vaccine; 2016 Aug; 34(36):4278-84. PubMed ID: 27423382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella zoster virus antibody detection: A comparison of four commonly used techniques.
    Otani N; Tanaka M; Maeda K; Gomi Y; Nakajima K; Tanimura S; Takesue Y; Shima M; Okuno T
    J Infect Chemother; 2016 Apr; 22(4):225-8. PubMed ID: 26867792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicella vaccination in children with nephrotic syndrome: a report of the Southwest Pediatric Nephrology Study Group.
    Furth SL; Arbus GS; Hogg R; Tarver J; Chan C; Fivush BA;
    J Pediatr; 2003 Feb; 142(2):145-8. PubMed ID: 12584535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 4 serological tests--complement fixation, neutralization, fluorescent antibody to membrane antigen and immune adherence hemagglutination--for assay of antibody to varicella-zoster (V-Z) virus.
    Yamada A; Ogino S; Asano Y; Otsuka T; Takahashi M; Baba K; Yabuuchi H
    Biken J; 1979 Jun; 22(2):55-60. PubMed ID: 231433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of immunogenicity and safety of VARIVAX™ New Seed Process (NSP) in children.
    Senders SD; Bundick ND; Li J; Zecca C; Helmond FA
    Hum Vaccin Immunother; 2018 Feb; 14(2):442-449. PubMed ID: 29087781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varicella vaccine without human serum albumin versus licensed varicella vaccine in children during the second year of life: a randomized, double-blind, non-inferiority trial.
    Prymula R; Simko R; Povey M; Kulcsar A
    BMC Pediatr; 2016 Jan; 16():7. PubMed ID: 26762528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, randomized, controlled, multi-center safety and immunogenicity study of a refrigerator-stable formulation of VARIVAX®.
    Reisinger KS; Richardson E; Malacaman EA; Levin MJ; Gardner JL; Wang W; Stek JE; Kuter B
    Vaccine; 2019 Sep; 37(38):5788-5795. PubMed ID: 30146405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.